India's fourth-largest drugmaker Cipla plans to increase focus on private market segment across core geographies and review participation in low margin tenders, besides addressing issues of supply ...

Drug maker Cipla, which draws a large portion of sales from domestic formulation business, is trying to streamline its distribution and looking for new ways to engage customers. The company has ...